Have any questions? 706-721-6582 or cts@augusta.edu
- S1933, “A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status”
Clinical Trial
S1933, “A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status”
Eligibility Criteria
- Participants must be ? 18 years of age Non-Small Cell Lung Cancer (NSCLC) Stage II or III NSCLC
RESEARCH. INNOVATION. DISCOVERY.